Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy

American Journal of Hematology

Volumn 52, Issue 4, 1996, Pages 310-312

  Mach Pascual, Sara ^a   Samii, Kaveh ^a   Beris, Photis ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

FK506; hemolysis; microangiopathic hemolytic anemia; tacrolimus

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADRENAL CORTEX HORMONES; ANEMIA, HEMOLYTIC; ASPIRIN; DIPYRIDAMOLE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA; PLASMA EXCHANGE; TACROLIMUS;

EID: 0029758419     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199608)52:4<310::AID-AJH11>3.0.CO;2-H     Document Type: Article

References (9)

1. Harding MW, Galat A, Uehling DE, Schreiber SL: A receptor for the immunosuppressunt FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341:758-60, 1989.
2. Tocci MJ, Matkovich TA, Collier KA, Kvok P, et al.: Immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 43:718-26, 1989.
3. Fung JJ, Alessiani M, Abu-Elmagd K, Todo S, et al.: Adverse effects associated with the use of FK506. Transpl Proc 23/6:3105-08, 1991.
4. Kwaan HC: Miscellaneous secondary thrombotic microangiopathy. Sem Hematol 24/3:141-47, 1987.
5. Neild GH: Haemolytic-uraemic syndrome in practice. Lancet 343:398-401, 1994.
6. Schmidt RJ, Venkat KK, Dumier F: Hemolytic-uremic syndrome in a renal transplant recipient on FK506 immunosuppression. Transpl Proc 23/6:3156-57, 1991.
7. Ichihashi T, Naoe T, Yoshida H, Kiyoi H, et al.: Hemolytic uraemic syndrome during FK506 therapy. Lancet 340:60-61, 1992.
8. McCauley J, Bronsther O, Fung J, Todo S, Starzl TE: Treatment of cyclosporin-induced heamolytic uraemic syndrome with FK506. Lancet 30:1516, 1989.
9. Scantlebury VP, Shapiro R, McCauley J, Jordan M, et al.: Renal transplantation under cyclosporine and FK506 for hemolytic uremic syndrome. Transpl Proc 27/1:842-43, 1995.